ArticleMedical science monitor : international medical journal of experimental and clinical research2026
Improved Prediction of Femoral Shortening in Total Hip Arthroplasty for Developmental Dysplasia of the Hip Using the Etfal Classification: A 7-Center Validation Study.
Article in Medical science monitor : international medical journal of experimental and clinical research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND Developmental dysplasia of the hip (DDH) presents substantial surgical challenges during total hip arthroplasty (THA), particularly in cases of high-riding dislocations, which can require subtrochanteric shortening osteotomy. The newly proposed Etfal classification incorporates the proportional femoral-pelvic ratio and may offer improved preoperative guidance. MATERIAL AND METHODS A retrospective multicenter validity study was conducted across 7 tertiary centers, including 152 patients with 157 hips who underwent THA for DDH. The primary endpoint was the intraoperative requirement for subtrochanteric shortening osteotomy. Preoperative radiographs were classified using the Etfal and Crowe classifications. Diagnostic performance was evaluated using ROC analyses, AUC values, and optimal thresholds determined using the Youden index. Complication associations were assessed using a 2×2 contingency analysis with odds ratios. RESULTS A total of 157 hips from 152 patients were analyzed, with subtrochanteric shortening osteotomy performed in 50 hips (31.8% of hips). Subtrochanteric shortening osteotomy was required in 0% of Etfal type 1; 33% of type 2; 96.4% of type 3; and 100% of type 4 hips. In contrast, only 6.1% of Crowe type 3 hips required subtrochanteric shortening osteotomy, compared with 80% of Crowe type 4 hips. Diagnostic performance favored Etfal over Crowe (AUC, 0.98 vs 0.94). Etfal type 3 or greater demonstrated near-perfect specificity (0.99) and high sensitivity (0.82), outperforming Crowe type 3 or greater (specificity, 0.60; sensitivity, 1.00). Twelve complications occurred, predominantly in Etfal types 3 and 4. CONCLUSIONS Etfal classification demonstrated superior discriminative ability for predicting the intraoperative requirement for subtrochanteric shortening osteotomy and complication risk compared with the Crowe system.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.